Get started
Author

Zoe Ngo

Observed institution: Stanford Health Care
OpenAlex ID: A5116168604
A novel decision tree for performing risk assessments of biologics in a health-system setting
2025 · Zoe Ngo, Scott Mayeda, et al. · Journal of Oncology Pharmacy Practice · 3
Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting
2025 · Austin Wang, Zoe Ngo, et al. · American Journal of Health-System Pharmacy · 2
The GAIN trial: Gemcitabine alternating with intravesical BCG randomized against BCG alone for patients with recurrent “BCG-exposed” high-grade non-muscle invasive bladder cancer (NMIBC) (ALLIANCE A032303).
2026 · Eugene J. Pietzak, Karla V. Ballman, et al. · Journal of Clinical Oncology · 1
Response to Satapathy et al
2026 · Zoe Ngo, Austin Wang, et al. · American Journal of Health-System Pharmacy
Response to letter to the editor: A novel decision tree for performing risk assessments of biologics in a health-system setting
2025 · Zoe Ngo, Scott Mayeda, et al. · Journal of Oncology Pharmacy Practice
Works count: 5
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type